MEDIUMBuilt-inCustomer
life science and other FDA-regulated businesses
“10-K Item 1A: 'Our Service segment has a concentration of customers in the life science and other FDA-regulated businesses'”
TRNS · Concentration risk · 10-K extracted
Transcat (TRNS) concentration risks
Updated
The most significant concentration Transcat discloses is life science and other FDA-regulated businesses, classified MEDIUM by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Transcat’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
At a glance
Disclosed-size breakdown · 1 disclosed concentration
HIGH0
MEDIUM1
LOW0
Disclosed concentrations
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
TrendMatrix Research · concentration synthesis
What these concentrations mean together
updated 2026-07-06Transcat's disclosed concentration is qualitative rather than quantified: the company states that its Service segment has a concentration of customers in life science and other FDA-regulated businesses, without disclosing a specific percentage. The filing characterizes this exposure at a medium share level and frames it as structural — meaning it reflects an inherent feature of how the Service segment's customer base is composed, tied to a specific regulated end-market, rather than dependency on a handful of named counterparties. Because no dollar or percentage figure accompanies the disclosure, the exact scale of the exposure cannot be quantified from the filing; what can be said is that the company itself flags life science and FDA-regulated customers as a definable segment-level concentration. For investors, structural concentration in a single regulated vertical carries a different risk profile than a dependency-type reliance on individual customers: it ties Service segment results to the health of life science and FDA-regulated end markets rather than to the retention of any one account. With only this single disclosed exposure, Transcat's overall concentration profile reads as moderate and sector-specific rather than broad-based across many customer types or geographies.
For the engine’s reasoning on TRNS’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
Industry peers · Specialty Business Services
Peer concentration profile
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| ARMK | Aramark | 1 | 1 | 0 | 2 |
| AMTM | Amentum Holdings, Inc. | 1 | 0 | 0 | 1 |
| BKSY | BlackSky Technology Inc. | 1 | 0 | 0 | 1 |
| TRNS● | Transcat, Inc. | 0 | 1 | 0 | 1 |
| ABM | ABM Industries Incorporated | 0 | 0 | 0 | 0 |
| AZZ | AZZ Inc. | 0 | 0 | 0 | 0 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.